IL17A and colorectal carcinoma: Furthermore, KEGG enrichment analysis also revealed that the novel signature involved in various classical tumor-related pathways, which participate in the initial and progression of CRC, including NF-κB signaling48, TNF signaling49, RIG-I-like receptor signaling50, IL-17 signaling51 and JAK/STAT signaling52.